4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001209191-19-057754
Director acquired 7,201 shares (option exercise)
- Director gave 7,201 shares (gift)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| TARNOW MICHAEL M Director | 2019-11-21 | Option exercise | +5,144 | $3.56 | $18,313 | 69,713 | D: show line 1 in the form |
| TARNOW MICHAEL M Director | 2019-11-21 | Gift | −5,144 | 64,569 | D: show line 2 in the form | ||
| TARNOW MICHAEL M Director | 2019-11-21 | Option exercise | +2,057 | $3.51 | $7,220 | 66,626 | D: show line 3 in the form |
| TARNOW MICHAEL M Director | 2019-11-21 | Gift | −2,057 | 64,569 | D: show line 4 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| TARNOW MICHAEL M Director | 2019-11-21 | Option exercise · Stock Option (Right to Buy) | −5,144 | 0 | D: show line 5 in the form | |||||
| TARNOW MICHAEL M Director | 2019-11-21 | Option exercise · Stock Option (Right to Buy) | −2,057 | 0 | D: show line 6 in the form |
Loading xslF345X03/doc4.xml…